原发性肝癌患者血清酸性铁蛋白的临床意义  

The Serum Level of AIF in Hepatocarcinoma and Its Clinical Significance

作　　者：姜敏 郑有贵 姜若兰 赵忠春[1] 张汉国[1] 

机构地区：[1]沈阳第一临床学院消化内科,沈阳第一临床学院介入科

出　　处：《中国医科大学学报》1996年第2期155-156,共2页Journal of China Medical University

摘　　要：本实验设正常对照、肝癌、肝硬化及胃肠道肿瘤４组，以放射免疫分析法检测各组血清酸性铁蛋白（ＡＩＦ）水平。结果：肝癌组ＡＩＦ的阳性率７５％，与其他各组相比均有显著性差异，同时ＡＩＦ阳性可以覆盖部分ＡＦＰ阴性患者，两者联合使用将提高肝癌的诊断率。he serum AIF level was measured in 56 patients with hepatocarcinoma and 46 normal subjects,30 liver cirrhosis and 33 gastrointestinal tumors as controls,Radioimmunoassay was used in the experi-ments. The results showed that the positive rate of AIF in hepatocarcinoma patients reached 75%,be-ing significantly different from those in the control groups, Some hepatocarcinoma patients with AFPnegative also appeared AIF positive. The combination of the detection of AIF and AFP would obviouslyincrease the diagnostic rate of hepatocarcinoma.

关 键 词：原发性 肝肿瘤 酸性铁蛋白 放射免疫分析 

分 类 号：R735.702[医药卫生—肿瘤]